Cargando…

Urinary Vitamin D Binding Protein: A Potential Novel Marker of Renal Interstitial Inflammation and Fibrosis

Non-invasive tubulointerstitial damage markers may allow better titration and monitoring of renoprotective therapy. We investigated the value of urinary vitamin D binding protein excretion (uVDBP) as a tubulointerstitial inflammation and fibrosis marker in adriamycin rats, and tested whether uVDBP p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mirković, Katarina, Doorenbos, Carolina R. C., Dam, Wendy A., Lambers Heerspink, Hiddo J., Slagman, Maartje C. J., Nauta, Ferdau L., Kramer, Andrea B., Gansevoort, Ronald T., van den Born, Jacob, Navis, Gerjan, de Borst, Martin H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3569442/ https://www.ncbi.nlm.nih.gov/pubmed/23409077 http://dx.doi.org/10.1371/journal.pone.0055887

Ejemplares similares

Proteinuria Triggers Renal Lymphangiogenesis Prior to the Development of Interstitial Fibrosis
por: Yazdani, Saleh, et al.
Publicado: (2012)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
por: Slagman, Maartje C J, et al.
Publicado: (2011)

Comment on: Ekinci et al. Dietary Salt Intake and Mortality in Patients With Type 2 Diabetes. Diabetes Care 2011;34:703–709
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels
por: Gant, Christina M., et al.
Publicado: (2017)

Vitamin D inhibits lymphangiogenesis through VDR-dependent mechanisms
por: Yazdani, Saleh, et al.
Publicado: (2017)

Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
por: Sinkeler, Steef J., et al.
Publicado: (2013)

Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
por: Van Raalte, Daniel H., et al.
Publicado: (2022)

New Diabetes Therapies and Diabetic Kidney Disease Progression: the Role of SGLT-2 Inhibitors
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

The Geographical Distribution of Leadership in Globalized Clinical Trials
por: Hoekman, Jarno, et al.
Publicado: (2012)

Glomerular and Tubular Damage Markers Are Elevated in Patients With Diabetes
por: Nauta, Ferdau L., et al.
Publicado: (2011)

Urinary potassium excretion and mortality risk in community-dwelling individuals with and without obesity
por: Yeung, Stanley M H, et al.
Publicado: (2022)

Growth-Differentiation Factor 15 Predicts Worsening of Albuminuria in Patients With Type 2 Diabetes
por: Hellemons, Merel E., et al.
Publicado: (2012)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

The Use of Surrogate Endpoints in Regulating Medicines for Cardio-Renal Disease: Opinions of Stakeholders
por: Schievink, Bauke, et al.
Publicado: (2014)

Fasting Proinsulin Independently Predicts Incident Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2022)

Insulin resistance, kidney outcomes and effects of the endothelin receptor antagonist atrasentan in patients with type 2 diabetes and chronic kidney disease
por: Smeijer, J. David, et al.
Publicado: (2023)

Predicting kidney failure from longitudinal kidney function trajectory: A comparison of models
por: van den Brand, Jan A. J. G., et al.
Publicado: (2019)

Plasma C-Peptide and Risk of Developing Type 2 Diabetes in the General Population
por: Sokooti, Sara, et al.
Publicado: (2020)

Targeting tubulointerstitial remodeling in proteinuric nephropathy in rats
por: Yazdani, Saleh, et al.
Publicado: (2015)

How to measure and monitor albuminuria in healthy toddlers?
por: van den Belt, Sophie Marielle, et al.
Publicado: (2018)

Effects of sodium glucose cotransporter 2 inhibitors on mineral metabolism in type 2 diabetes mellitus
por: Vinke, Joanna Sophia J., et al.
Publicado: (2019)

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers
por: Dekkers, Claire C. J., et al.
Publicado: (2018)

Prevalence and Effects of Functional Vitamin K Insufficiency: The PREVEND Study
por: Riphagen, Ineke J., et al.
Publicado: (2017)

Urinary collagen degradation products as early markers of progressive renal fibrosis
por: Hijmans, Ryanne S., et al.
Publicado: (2017)

Association of Plasma Concentration of Vitamin B(12) With All-Cause Mortality in the General Population in the Netherlands
por: Flores-Guerrero, Jose L., et al.
Publicado: (2020)

The effect of sodium/glucose cotransporter 2 (SGLT2) inhibition on the urinary proteome
por: Cherney, David, et al.
Publicado: (2017)

Improving clinical trial efficiency by biomarker-guided patient selection
por: Boessen, Ruud, et al.
Publicado: (2014)

Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney
por: Heerspink, Hiddo J L
Publicado: (2019)

Plasma calcidiol, calcitriol, and parathyroid hormone and risk of new onset heart failure in a population‐based cohort study
por: Meems, Laura M. G., et al.
Publicado: (2016)

Initial Angiotensin Receptor Blockade–Induced Decrease in Albuminuria Is Associated With Long-Term Renal Outcome in Type 2 Diabetic Patients With Microalbuminuria: A post hoc analysis of the IRMA-2 trial
por: Hellemons, Merel E., et al.
Publicado: (2011)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
por: Vart, Priya, et al.
Publicado: (2022)

The association between reverse total shoulder arthroplasty neck-shaft angle on postoperative patient experienced shoulder disability: a retrospective cohort study
por: Engelen, Bob, et al.
Publicado: (2022)

Treating diabetic complications; from large randomized clinical trials to precision medicine
por: Heerspink, Hiddo J. L., et al.
Publicado: (2018)

Novel anti-inflammatory drugs for the treatment of diabetic kidney disease
por: Heerspink, Hiddo J. L., et al.
Publicado: (2016)

Time for clinical decision support systems tailoring individual patient therapy to improve renal and cardiovascular outcomes in diabetes and nephropathy
por: de Zeeuw, Dick, et al.
Publicado: (2020)

Associations of 24 h urinary excretions of α- and γ-carboxyethyl hydroxychroman with plasma α- and γ-tocopherol and dietary vitamin E intake in older adults: the Lifelines-MINUTHE Study
por: Zhu, Yinjie, et al.
Publicado: (2022)

Plasma Vitamin C and Cancer Mortality in Kidney Transplant Recipients
por: Gacitúa, Tomás A., et al.
Publicado: (2019)

Fibroblast growth factor 23 and new-onset chronic kidney disease in the general population: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study
por: De Jong, Maarten A, et al.
Publicado: (2020)

Monoclonal Antibody RYSK173 Recognizes the Dinuclear Zn Center of Serum Carnosinase 1 (CN-1): Possible Consequences of Zn Binding for CN-1 Recognition by RYSK173
por: Zhang, Shiqi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_epv4mujb0g6kscj6rgb088i6sd